{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:42:36Z","timestamp":1762864956472},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1995,7]]},"DOI":"10.1007\/bf01774018","type":"journal-article","created":{"date-parts":[[2005,6,18]],"date-time":"2005-06-18T18:27:12Z","timestamp":1119119232000},"page":"276-280","source":"Crossref","is-referenced-by-count":65,"title":["Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy"],"prefix":"10.1007","volume":"5","author":[{"given":"B. J.","family":"Riis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01774018_CR1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9378(82)90176-4","volume":"144","author":"MS Christensen","year":"1982","unstructured":"Christensen MS, Hagen C, Christiansen C, Transb\u00f8l I. Dose-response evaluation of cyclic estrogen\/gestagen in postmeno-pausal women: placebo-controlled trial of its gynecologic and metabolic actions. Am J Obstet Gynecol 1982;144:873\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"BF01774018_CR2","first-page":"759","volume":"63","author":"R Lindsay","year":"1984","unstructured":"Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759\u201363.","journal-title":"Obstet Gynecol"},{"key":"BF01774018_CR3","first-page":"99","volume":"1","author":"RP Heaney","year":"1986","unstructured":"Heaney RP. En recherche de la difference (p<0.05). Bone Miner 1986;1:99\u2013114.","journal-title":"Bone Miner"},{"key":"BF01774018_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jcem-61-5-905","volume":"61","author":"CC Johnston Jr","year":"1985","unstructured":"Johnston CC Jr, Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab 1985;61:905\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01774018_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9378(87)90203-1","volume":"156","author":"BJ Riis","year":"1987","unstructured":"Riis BJ, Thomsen K, Str\u00f8m V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987;156:61\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"BF01774018_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2265.1987.tb00790.x","volume":"26","author":"BJ Riis","year":"1987","unstructured":"Riis BJ, Jensen J, Christiansen C. Cyproterone acetate, and alternative gestagen in postmenopausal oestrogen\/gestagen therapy. Clin Endocrinol 1987;26:327\u201334.","journal-title":"Clin Endocrinol"},{"key":"BF01774018_CR7","first-page":"202","volume":"79","author":"U Marslew","year":"1992","unstructured":"Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects of bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992;79:202\u201310.","journal-title":"Obstet Gynecol"},{"key":"BF01774018_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2362.1991.tb01416.x","volume":"21","author":"U Marslew","year":"1991","unstructured":"Marslew U, Riis BJ, Christiansen C. Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Eur J Clin Invest 1991;21:601\u20137.","journal-title":"Eur J Clin Invest"},{"key":"BF01774018_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/00365519009089166","volume":"50","author":"MA Hansen","year":"1990","unstructured":"Hansen MA, Riis BJ, Overgaard K, Hassager C, Christiansen C. Bone mass measured by photon absorptiometry: comparison of forearm, heel and spine. Scand J Clin Lab Invest 1990;50:517\u201323.","journal-title":"Scand J Clin Lab Invest"},{"key":"BF01774018_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0026-0495(89)90256-4","volume":"38","author":"C Hassager","year":"1989","unstructured":"Hassager C, Borg J, Christiansen C. Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry. Metabolism 1989;38:159\u201365.","journal-title":"Metabolism"},{"key":"BF01774018_CR11","first-page":"1156","volume":"31","author":"MA Hansen","year":"1990","unstructured":"Hansen MA, Hassager C, Overgaard K, Marslew U, Riis BJ, Christiansen C. Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density on the lumbar spine. J Nucl Med 1990;31:1156\u201362.","journal-title":"J Nucl Med"},{"key":"BF01774018_CR12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1530\/acta.0.1140410","volume":"114","author":"JS Johansen","year":"1987","unstructured":"Johansen JS. M\u00f8lholm Hansen JE, Christiansen C. A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol 1987;114:410\u20136.","journal-title":"Acta Endocrinol"},{"key":"BF01774018_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0009-8981(84)90110-4","volume":"142","author":"J P\u00f8denphant","year":"1984","unstructured":"P\u00f8denphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984;142:145\u20138.","journal-title":"Clin Chim Acta"},{"key":"BF01774018_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","volume":"298","author":"I Persson","year":"1989","unstructured":"Persson I, Adami H-O, Bergkvist L, Lindgren A, Pettersson B, Hoover R, Schairer C. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 1989;298:147\u201351.","journal-title":"BMJ"},{"key":"BF01774018_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293\u20137.","journal-title":"N Engl J Med"},{"key":"BF01774018_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02352259","volume":"4","author":"C Hassager","year":"1994","unstructured":"Hassager C, Jensen SB, Christiansen C. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss. Do they exist? Osteoporosis Int 1994;4:36\u201341.","journal-title":"Osteoporosis Int"},{"key":"BF01774018_CR17","first-page":"105","volume":"1","author":"C Christiansen","year":"1987","unstructured":"Christiansen C, Riis BJ, R\u00f8dbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:105\u20138.","journal-title":"Lancet"},{"key":"BF01774018_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01880414","volume":"1","author":"C Christiansen","year":"1990","unstructured":"Christiansen C, Riis BJ, R\u00f8dbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1990;1:35\u201340.","journal-title":"Osteoporosis Int"},{"key":"BF01774018_CR19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.303.6808.961","volume":"303","author":"MA Hansen","year":"1991","unstructured":"Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 1991;303:961\u20134.","journal-title":"BMJ"},{"key":"BF01774018_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2362.1988.tb02412.x","volume":"18","author":"JS Johansen","year":"1988","unstructured":"Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988;18:191\u20135.","journal-title":"Eur J Clin Invest"},{"key":"BF01774018_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.299.6697.477","volume":"299","author":"K Overgaard","year":"1989","unstructured":"Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of salcatonin given intranasally on early postmenopausal bone loss. BMJ 1989;299:477\u20139.","journal-title":"BMJ"},{"key":"BF01774018_CR22","first-page":"1861","volume-title":"Proceedings of the third international symposium on osteoporosis","author":"PJ Meunier","year":"1990","unstructured":"Meunier PJ, Delmas PD, Chaumet-Riffaud PD. Intranasal salmon calcitonin for prevention of postmenopausal bone loss: a placebo-controlled study in 109 women. In: Christiansen C, Overgaard K, editors. Proceedings of the third international symposium on osteoporosis. Copenhagen, Denmark: Osteopress ApS 1990;1861\u20137."},{"key":"BF01774018_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73\u20139.","journal-title":"N Engl J Med"},{"key":"BF01774018_CR24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, S\u00f8rensen OH. Effect of intermittent cyclical therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265\u201371.","journal-title":"N Engl J Med"},{"key":"BF01774018_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","volume":"8","author":"D Uebelhart","year":"1990","unstructured":"Uebelhart D, Gineyts E, Chapuy M-C, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87\u201396.","journal-title":"Bone Miner"},{"key":"BF01774018_CR26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.5650060615","volume":"6","author":"PD Delmas","year":"1991","unstructured":"Delmas PD, Schlemmer A, Gineyts E, Riis BJ, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone miner Res 1991;6:639\u201344.","journal-title":"J Bone miner Res"},{"key":"BF01774018_CR27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-72-2-367","volume":"72","author":"D Uebelhart","year":"1991","unstructured":"Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991;72:367\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01774018_CR28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jbmr.5650080515","volume":"8","author":"SM Seyedin","year":"1993","unstructured":"Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635\u201341.","journal-title":"J Bone Miner Res"},{"key":"BF01774018_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","volume":"7","author":"DA Hanson","year":"1992","unstructured":"Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251\u20138.","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01774018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01774018\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01774018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T13:27:26Z","timestamp":1557322046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01774018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["BF01774018"],"URL":"https:\/\/doi.org\/10.1007\/bf01774018","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}